Based on the evaluation results of Shanghai Ellis preclinical pharmacodynamics and safety evaluation trials and the target product profile, before the IND application, 200 mg thin film tablets based on aftinib (C28H31F3N8O2) were developed, and a clinical trial registration application was submitted , With the batch number 2016L07983.
正在翻译中..